Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Beam Therapeutics Inc.

Present initial data on multiple cohorts for BEAM-302

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
13 Jan 2025
Due
30 Jun 2025
Delivered
April 2025
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Present initial data on multiple cohorts in 1H 2025”

What we found

Evidence strength A What the grades mean

The company announced initial safety and efficacy data from nine patients in the BEAM-302 dose escalation trial during March and April 2025, meeting the first-half 2025 commitment.

  • A
    Beam Therapeutics Inc. 10-Q filed 2025-08-05 Regulatory filing · published 5 Aug 2025 · retrieved 2 Oct 2026 · kept permanently by the SEC
    “In March and April 2025, we announced positive initial safety and efficacy data from nine patients in the dose escalation portion of the trial” ✓ confirmed on the page

Market reaction: the shares moved -6.8% against the S&P 500 over the three sessions around the disclosure (4 Aug 2025 to 7 Aug 2025). What this measures

Checked 2 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Present
Deliverable
BEAM-302 AATD initial data
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Beam Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2025-BEAM-003293 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.